|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arbyn M, Castellsagué X, Sanjosé SD, Bruni
L, Saraiya M, Bray F and Ferlay J: Worldwide burden of cervical
cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsuki M, Takahashi A, Katou S,
Takayanagi A, Takagi Y and Kamata K: Pathological complete response
to gemcitabine and cisplatin chemotherapy for advanced upper tract
urothelial carcinoma: A case report. Nihon Hinyokika Gakkai Zasshi.
104:33–37. 2013.(In Japanese). PubMed/NCBI
|
|
4
|
Pignon JP, Tribodet H, Scagliotti GV,
Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell
R, Seymour L, et al: Lung adjuvant cisplatin evaluation: A pooled
analysis by the LACE collaborative group. J Clin Oncol.
20:3552–3559. 2008. View Article : Google Scholar
|
|
5
|
Agarwal R and Kaye SB: Ovarian cancer:
Strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang D and Lippard SJ: Cellular processing
of platinum anticancer drugs. Nat Rev Drug Discov. 4:307–320. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hernandez-Flores G, Ortiz-Lazareno PC,
Lerma-Diaz JM, Dominguez-Rodriguez JR, Jave-Suarez LF, Adel
Aguilar-Lemarroy C, de Celis-Carrillo R, del Toro-Arreola S,
Castellanos-Esparza YC and Bravo-Cuellar A: Pentoxifylline
sensitizes human cervical tumor cells to cisplatin-induced
apoptosis by suppressing NF-kappa B and decreased cell senescence.
BMC Cancer. 11:4832011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Astolfi L, Ghiselli S, Guaran V, Chicca M,
Simoni E, Olivetto E, Lelli G and Martini A: Correlation of adverse
effects of cisplatin administration in patients affected by solid
tumours: A retrospective evaluation. Oncol Rep. 29:1285–1292. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kirwan JM, Symonds P, Green JA, Tierney J,
Collingwood M and Williams CJ: A systematic review of acute and
late toxicity of concomitant chemoradiation for cervical cancer.
Radiother Oncol. 68:217–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
You BR, Moon HJ, Han YH and Park WH:
Gallic acid inhibits the growth of HeLa cervical cancer cells via
apoptosis and/or necrosis. Food Chem Toxicol. 48:1334–1340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karthikeyan S, Kanimozhi G, Prasad NR and
Mahalakshmi R: Radiosensitizing effect of ferulic acid on human
cervical carcinoma cells in vitro. Toxicol In Vitro. 25:1366–1375.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hussain A, Priyani A, Sadrieh L,
Brahmbhatt K, Ahmed M and Sharma C: Concurrent sulforaphane and
eugenol induces differential effects on human cervical cancer
cells. Integr Cancer Ther. 11:154–165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masuda T, Yamada K, Akiyama J, Someya T,
Odaka Y, Takeda Y, Tori M, Nakashima K, Maekawa T and Sone Y:
Antioxidation mechanism studies of caffeic acid: Identification of
antioxidation products of methyl caffeate from lipid oxidation. J
Agric Food Chem. 56:5947–5952. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang HJ, Park HJ, Chung HJ, Min HY, Park
EJ, Hong JY and Lee SK: Inhibitory effects of caffeic acid
phenethyl ester on cancer cell metastasis mediated by the
down-regulation of matrix metalloproteinase expression in human
HT1080 fibrosarcoma cells. J Nutr Biochem. 17:356–362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang WC, Hsieh CH, Hsiao MW, Lin WC, Hung
YC and Ye JC: Caffeic acid induces apoptosis in human cervical
cancer cells through the mitochondrial pathway. Taiwan J Obstet
Gynecol. 49:419–424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh M, Bhui K, Singh R and Shukla Y: Tea
polyphenols enhance cisplatin chemosensitivity in cervical cancer
cells via induction of apoptosis. Life Sci. 93:7–16. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Provan GJ and Helliwell K:
Determination of rosmarinic acid and caffeic acid in aromatic herbs
by HPLC. Food Chem. 87:307–311. 2004. View Article : Google Scholar
|
|
19
|
Hemaiswarya S and Doble M: Combination of
phenylpropanoids with 5-fluorouracil as anti-cancer agents against
human cervical cancer (HeLa) cell line. Phytomedicine. 20:151–158.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pinmai K, Chunlaratthanabhorn S,
Ngamkitidechakul C, Soonthornchareon N and Hahnvajanawong C:
Synergistic growth inhibitory effects of Phyllanthus emblica
and Terminalia bellerica extracts with conventional
cytotoxic agents: Doxorubicin and cisplatin against human
hepatocellular carcinoma and lung cancer cells. World J
Gastroenterol. 14:1491–1497. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galvao J, Davis B, Tilley M, Normando E,
Duchen MR and Cordeiro MF: Unexpected low-dose toxicity of the
universal solvent DMSO. FASEB J. 28:1317–1330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Malinin TI and Perry VP: Toxicity of
dimethyl sulfoxide on HeLa cells. Cryobiology. 4:90–96. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rose PG: Chemoradiotherapy for cervical
cancer. Eur J Cancer. 38:270–278. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eifel PJ: Chemoradiotherapy in the
treatment of cervical cancer. Semin Radiat Oncol. 16:177–185. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meissner JD: Nucleotide sequences and
further characterization of human papillomavirus DNA present in the
CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol.
80:1725–1733. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crook T, Wrede D and Vousden KH: p53 point
mutation in HPV negative human cervical carcinoma cell lines.
Oncogene. 6:873–875. 1991.PubMed/NCBI
|
|
28
|
Saxena A, Yashar C, Taylor DD and
Gercel-Taylor C: Cellular response to chemotherapy and radiation in
cervical cancer. Am J Obstet Gynecol. 192:1399–1403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Funaoka K, Shindoh M, Yamashita T,
Fujinaga K, Amemiya A and Totsuka Y: High-risk HPV-positive human
cancer cell lines show different sensitivity to cisplatin-induced
apoptosis correlated with the p21 Waf1/Cip1 level. Cancer Lett.
108:15–23. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daduang J, Palasap A, Daduang S, Boonsiri
P, Suwannalert P and Limpaiboon T: Gallic acid enhancement of gold
nanoparticle anticancer activity in cervical cancer cells. Asian
Pac J Cancer Prev. 16:169–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Promraksa B, Daduang J, Khampitak T,
Tavichakorntrakool R, Koraneekit A, Palasap A, Tangrassameeprasert
R and Boonsiri P: Anticancer potential of Cratoxylum
formosum subsp. pruniflorum (Kurz.) gogel extracts
against cervical cancer cell lines. Asian Pac J Cancer Prev.
16:6117–6121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prabhakara PK, Kumarb A and Doblec M:
Combination therapy: A new strategy to manage diabetes and its
complications. Phytomedicine. 21:123–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rosendahl AH, Perks CM, Zeng L, Markkula
A, Simonsson M, Rose C, Ingvar C, Holly JM and Jernstrom H:
Caffeine and caffeic acid lnhibit growth and modify estrogen
receptor and insulin-like growth factor I receptor levels in human
breast cancer. Clin Cancer Res. 21:1877–1887. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prasad NR, Karthikeyan A, Karthikeyan S
and Reddy BV: Inhibitory effect of caffeic acid on cancer cell
proliferation by oxidative mechanism in human HT-1080 fibrosarcoma
cell line. Mol Cell Biochem. 349:11–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Galati G, Sabzevari O, Wilson JX and
O'Brien PJ: Prooxidant activity and cellular effects of the
phenoxyl radicals of dietary flavonoids and other polyphenolics.
Toxicology. 177:91–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Onoa GB, Cervantes G, Moreno V and Prieto
MJ: Study of the interaction of DNA with cisplatin and other Pd(II)
and Pt(II) complexes by atomic force microscopy. Nucleic Acids Res.
26:1473–1480. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Xing H, Han X, Shi X, Liang F, Chen
G and Ma D: The mechanism of cisplatin-induced apoptosis in HeLa
cells. J Clin Oncol. 2:866–869. 2005.
|
|
38
|
Rao Z, Gao J, Zhang B, Yang B and Zhang J:
Cisplatin sensitivity and mechanisms of anti-HPV16 E6-ribozyme on
cervical carcinoma CaSKi cell line. Chinese-German J Clin Oncol.
11:237–242. 2012. View Article : Google Scholar
|
|
39
|
Putral LN, Bywater MJ, Gu W, Saunders NA,
Gabrielli BG, Leggatt GR and McMillan NA: RNA interference against
human papillomavirus oncogenes in cervical cancer cells results in
increased sensitivity to cisplatin. Mol Pharmacol. 68:1311–1319.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ye S, Shen J, Choy E, Yang C, Mankin H,
Hornicek F and Duan Z: p53 overexpression increases
chemosensitivity in multidrug-resistant osteosarcoma cell lines.
Cancer Chemother Pharmacol. 77:349–356. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Seki K, Yoshikawa H, Shiiki K, Hamada Y,
Akamatsu N and Tasaka K: Cisplatin (CDDP) specifically induces
apoptosis via sequential activation of caspase-8, −3 and −6 in
osteosarcoma. Cancer Chemother Pharmacol. 45:199–206. 2000.
View Article : Google Scholar : PubMed/NCBI
|
